Table 1.
Variable | Hazard ratio (95% confidence interval) | Probability | Hazard points |
---|---|---|---|
Age <45 or >65 years | 4.12 (2.35‐7.23) | 0.0000008 | 3 |
FVCa <80% predicted | 2.13 (1.25‐3.63) | 0.0054374 | 1 |
DLCO/VA b <70% predicted | 2.62 (1.60‐4.29) | 0.0001292 | 2 |
N2c | 3.56 (2.20‐5.76) | 0.0000002 | 2.5 |
N3c | 8.65 (1.10‐68.21) | 0.0406576 | 7.5 |
Time to surgery >60 daysd | 4.04 (2.07‐7.88) | 0.0000408 | 3 |
Solid histologic subtypee | 2.09 (1.27‐3.43) | 0.0035422 | 1 |
LADERSf | 0‐20 |
FVC, forced vital capacity. Compared with FVC ≥80% predicted. When FVC not available, GOLD COPD ≥stage II was used in the Tours cohort.
DLCO/VA, Lung diffusion capacity for carbon monoxide corrected for alveolar ventilation. Compared with DLCO/VA ≥70% predicted. When DLCO/VA not available, current smoking was used in the Tours cohort.
N, cTNM7 nodal status descriptors. Compared with pooled patients with N0 and N1.
Compared with patients operated within 60 days from diagnosis.
Compared with all other histologic subtypes combined, including lepidic, acinar, papillary, micropapillary, adenosquamous, fetal, and non‐specified.
Rounded to the lower integer when decimal.